Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

Baicalin may help treat severe drug-induced skin reactions.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Baricitinib may not always prevent relapse in alopecia areata.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Tofacitinib is effective and safe for treating alopecia areata.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

Integrin-linked kinase is crucial for normal skin healing.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Blocking LFA-1 prevents hair loss in mice.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Tofacitinib might be used to treat hair loss.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Upadacitinib effectively treats psoriasis and lichen planus together.

Isoginkgetin reduces inflammation in cells by blocking NF-κB activation.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Bimekizumab effectively treated a man's chronic beard hair loss.